Stoke Therapeutics (STOK) Leases: 2022-2025
Historic Leases for Stoke Therapeutics (STOK) over the last 4 years, with Sep 2025 value amounting to $3.7 million.
- Stoke Therapeutics' Leases fell 24.76% to $3.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $3.7 million, marking a year-over-year decrease of 24.76%. This contributed to the annual value of $4.3 million for FY2024, which is 5.98% up from last year.
- As of Q3 2025, Stoke Therapeutics' Leases stood at $3.7 million, which was up 15.23% from $3.2 million recorded in Q2 2025.
- Over the past 5 years, Stoke Therapeutics' Leases peaked at $6.1 million during Q1 2024, and registered a low of $3.1 million during Q3 2023.
- Over the past 3 years, Stoke Therapeutics' median Leases value was $4.1 million (recorded in 2023), while the average stood at $4.2 million.
- In the last 5 years, Stoke Therapeutics' Leases slumped by 41.76% in 2023 and then spiked by 59.79% in 2024.
- Stoke Therapeutics' Leases (Quarterly) stood at $4.8 million in 2022, then decreased by 13.74% to $4.1 million in 2023, then rose by 5.98% to $4.3 million in 2024, then declined by 24.76% to $3.7 million in 2025.
- Its Leases stands at $3.7 million for Q3 2025, versus $3.2 million for Q2 2025 and $3.8 million for Q1 2025.